Skip to content
2000
Volume 17, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Individuals suffering from mental illnesses, unfortunately, have a shorter lifespan. An increase in mortality rates is primarily due to physical illness, unhealthy lifestyle, and associated comorbidities. Antipsychotic medications, previously known as tranquilizers, antipsychotics, or neuroleptics, can alleviate or attenuate symptoms related to psychosis, delusion, and/or hallucinations and are used in the treatment of psychosis, schizophrenia, bipolar disorder, depression, or Alzheimer's disease. Within hours to days, these medications alleviate symptoms and reduce confusion in individuals with psychosis; however, the full effect may take longer than usual in some cases. Importantly, these drugs do not cure the disease, but only treat the symptoms of the disease. The treatment is adjusted to reduce any psychotic symptoms while keeping the adverse effects to a minimum level. Antipsychotics may lead to increased risk of diseases, including but not limited to, diabetes, obesity, metabolic disorders, cardiovascular, renal, or respiratory disorders. Improved dosages, polypharmacy, and age-specific treatment play an important role in limiting the comorbidities, as well as the side effects. Further research and clinical attention are required to understand the functioning of these medications. The review focuses on the use of antipsychotic medications in different diseases and their effect on mental health.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886317666220216101106
2022-11-01
2024-12-26
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886317666220216101106
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test